No Data
No Data
Voyager Therapeutics up 8% Following Quarterly Beats
European Buy-rated Stocks That Trade Cheaply Vs. Their U.S. Peers - UBS
Express News | NYSE Order Imbalance 64369.0 Shares on Sell Side
MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths'
MacroGenics Inc (NASDAQ:MGNX) released interim data from the TAMARACK Phase 2 study of vobramitamab duocarmazine (vobra duo).TAMARACK is being conducted in previously treated patients with metastatic
Express News | Novartis Gets FDA Breakthrough Designation For Scemblix
Express News | NYSE Order Imbalance 55282.0 Shares on Sell Side
No Data